Recommended Global Gastroenterology Conferences
Conference Series invites you to attend 7th International Conference on Hepatology (Hepatology 2019) to be held in Sydney, Australia during July 15-16, 2019. The conference highlights the theme “Recent Advancements in the field of Hepatology’’
Hepatology 2019 is a best platform with its well organized scientific program to the audience which includes symposiums, workshops, keynote lectures, plenary talks, panel discussions and poster sessions on latest research and technological developments in the arena as well as therapeutic aspects. The conference invites Hepatologists, Gastroenterologists, Internists, Physicians, Microbiologists, Virologists, Pathologists, Oncologists, Surgeons, Toxicologists, Researchers, Students, Business delegates and Young researchers across the globe.
Conference Series organizes 300+ International Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific Societies and publishes 400+ Open Access Journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.
Scope of the Conference
Hepatology 2019 provides a great platform by gathering eminent professors, Researchers, Students and delegates to exchange new ideas. The conference will cover a wide range of topics and allow participants to discuss about the management of liver diseases. Hepatology 2019 conference consists of keynote and plenary lectures, special sessions (Workshop and Symposium), Young Researcher Forum and Poster presentations. Best poster presenters will be judged and awarded during the conference. To encourage broad participation from all over the world Conference Series Ltd is offering reduced registration fee for students.
For Researchers and Faculty Members:
Symposium hosting (4-5 member team)
For Universities, Associations & Societies:
For Students and Research Scholars:
Poster Competition (Winner will get Best Poster Award)
Young Researcher Forum (YRF Award to the best presenter)
For Business Delegates:
Book Launch event
For Product Manufacturers:
Exhibitor and Vendor booths
Marketing and Networking with clients
Sessions and Tracks
Liver and Biliary:
The liver is the largest gland in the body, and conducts a myriad of vital metabolic and excretory functions. In addition, by virtue of its circulatory relationship to the absorptive surface of the gastrointestinal tract, the liver is the initial site where ingested nutrients, and other substances entering via the gastrointestinal tract, such as drugs and bacterial metabolites, are processed by the body. Thus, the liver is a gate-keeper that can process useful substances while detoxifying orally absorbed substances that are potentially harmful, such as toxic xenobiotics.
Multidisciplinary treatment of liver malignancies
Minimally invasive liver surgery
Liver and biliary tree imaging
Liver is responsible for many critical functions within the body. It helps your body digest food, store energy, and remove poisons. If it becomes diseased or injured, the loss of those functions can cause significant damage to the body. There are over 100 different forms of liver disease that affect men, women and children. These diseases include cirrhosis, alcohol abuse, hepatitis A, B, C, D, and E, Epstein Barr virus (infectious mononucleosis), non-alcoholic fatty liver disease and iron overload (hemochromatosis). The main symptoms of liver imbalance include weakness and fatigue, weight loss, nausea, vomiting, and yellow discoloration of the skin (jaundice).
Fatty liver Disease
Primary Biliary Cirrhosis
Acute and Chronic Liver Disease
Fulminant Liver failure
Liver Diseases Diagnosis
Screening for Liver diseases has been advocated with the intention of intervening to halt its progression. Abnormal liver tests are those that measure synthesis of proteins made by the liver (albumin, clotting factors) or the liver's capacity to metabolize drugs. The impact of diagnosis of hepatitis C virus on quality of life is worse in patients aware of their viral status compared with individuals unaware of their viral status.
Shear Wave Elastography
Herbal Medicines for Liver diseases
The use of herbal products as medications has its origin thousands of years ago. In Western countries, herbal medicine products are gaining increasing popularity. Some herbal products may potentially benefit people with liver disease.
Herbal medicine induced Liver injury
Dietary supplements induced liver injury
Chinese medicine for liver disease
Pregnancy and Liver Diseases
Several disorders contribute to liver disease in pregnancy such as acute fatty liver of pregnancy (AFLP) and intrahepatic cholestasis of pregnancy (IHCP), hyperemesis gravidarum and hemolysis and elevated liver enzymes and low platelets (HELLP) syndrome. Liver disease such as acute viral hepatitis can occur in pregnancy and pregnancy may occur in a patient with underlying chronic liver disease including patients with cirrhosis and portal hypertension, and patients who have undergone liver transplantation.
Hepatitis during pregnancy
Acute Fatty liver of pregnancy
Intrahepatic cholestasis of pregnancy
Viral Hepatitis C
Hepatitis C is a devastating viral disease that generally progresses slowly, meaning patients often remain asymptomatic and unaware they are infected until very serious and often expensive complications emerge as a result of damage to the liver. It is estimated that about half of those infected are not aware that they carry the virus. The recent remarkable advances in treating hepatitis C built on incremental improvements achieved over the previous two decades to transform hepatitis C from a chronic, fatal disease, to an infection that with new and forthcoming treatments, can be potentially cured.
Hepatitis B is a liver infection caused by the Hepatitis B virus (HBV). HBV is transmitted through activities that involve percutaneous or mucosal contact with infectious blood or body fluids. HBV can survive outside the body at least 7 days and still be capable of causing infection. The best way to prevent hepatitis B is by getting the hepatitis B vaccine. The pathogenesis and clinical manifestations of hepatitis B are due to the interaction of the virus and the host immune system, which lead to liver injury and potentially cirrhosis and hepatocellular carcinoma. Patients can have either an acute symptomatic disease or an asymptomatic disease.
Hepatitis B: Management strategies
Novel Therapies for HBV
Prevention, Care and for Hepatitis B Infection
Non-viral hepatitis is an inflammation of the liver caused by toxins, drugs, or other harmful chemicals that destroy cells in the liver (Hepatocytes). Acute hepatitis damages hepatocytes, make up 70-85% of the total mass of the liver. The disease is a growing problem due to the increasing number of dietary supplements with liver side effects. If hepatitis leads to liver failure, a liver transplant is the only treatment option that can improve survival.
Overall, about one-third of people with HIV also have hepatitis C. Hepatitis C virus (HCV) can be transmitted in some of the same ways as HIV and hepatitis B. HIV can worsen hepatitis C. HIV not only increase the risk of liver damage, but it can also speed up the onset of liver damage following infection. People who are coinfected with HIV and HCV should work closely with health care providers in order to monitor and treat both conditions.
Management of HCV in HIV-Coinfected Individuals
The best way to prevent hepatitis is by getting the hepatitis vaccines. Vaccination is safe and effective and it is recommended for all. Efforts to develop a hepatitis C vaccine started more than 20 years ago, when the hepatitis C virus was identified. The hepatitis C virus is more variable than are the viruses that cause hepatitis A and hepatitis B. Hepatitis C virus occurs in at least six genetically distinct forms with 50 subtypes. A global vaccine would have to protect against all these variants of the virus.
Liver Transplantation and Surgery
Liver transplantation surgery technique to replace a diseased or injured liver with a healthy liver delivered from a healthy person. The liver is involved in various metabolic functioning including metabolism of drugs and toxins, removing degradation products of normal body metabolism (for example clearance of ammonia and bilirubin from the blood), and synthesis of many important proteins and enzymes (such as factors necessary for blood to clot). Doctors or surgeons suggest liver transplant surgery to the patients who suffer from severe Drug-induced liver injury (DILI) or Chronic liver failure. This surgery carries a risk of other complications including infection, liver inflammation, blood clots, liver rejection, and memory thinking problems.
Pancreas being a very close part to the liver helps to regulate sugar level in the body and also helps in many other functions. It is this part of the body that extremely helps in regulation of glucose level in the body.
Gastroenterology is the study of detailed understanding of the physiology of the gastrointestinal organs including the movement of material through the stomach and intestine the digestion and absorption of nutrients into the body, removal of waste from the system, and the function of the liver as a digestive organ.
Hepatology, traditionally considered a sub-specialty of gastroenterology, is the branch of internal medicine that incorporates the study of liver, biliary tree, gallbladder and pancreas as well as management of disease and disorders associated with them. Some of the cases in hepatology include jaundice, liver cancer, liver transplantation, drug overdose, bilary infection bleeding, pancreatitis, GIT bleeding, etc. Although there is a reduction in deaths due to gallstone disease and gallbladder cancer, liver-related mortality has remained relatively stable over the last 30 years. Hepatology represents a growing problem for the international health care systems and first of all, for the patients. Alcoholism and the alcoholic liver disease resulting from it, is a remarkable factor in some Asian countries and in most industrial countries but here the rapidly growing segment in hepatology is NASH (non-alcoholic steatohepatitis). NASH is the major form of NAFLD, the major cause of cryptogenic liver cirrhosis. Nearly 10% of the US Americans (25 Million) suffer with liver-related diseases every year. Chronic liver diseases are the major problem. An estimated 30% of the world's overall population (2 billion) has been infected with hepatitis B virus and more than 350 million people are Inflicted by chronic HBV. About 170 million people have hepatitis C. Global Liver Disease Treatment Market is foreseen to collect $19,536 million by 2022, registering a CAGR of 11.72% during the forecast period 2016 - 2022. Additionally, according to the reports of American Cancer Society, liver cancer rates raises 2.7% each year driving the growth of market.
This conference unleashes the novel ideas and advanced diagnostic approaches towards the diseases associated to liver. The recent advancements and knowledge about liver and pancreatic diseases and the treatment strategies will be shared. The participant companies can gain the networks and promote their upcoming strategies by exhibitting their products at the conference
The major intention of this conference is to bring together the Hepatologists, Gastroenterologists, Pathologists, Directors/CEO & Industry experts, Professors, Scientists, Researchers and Students of Hepatology in all areas of Liver diseases & Therapeutics and to provide an international forum for the exposure and dissemination of original research results, novel ideas and practical development experiences related to the research.
Association of Hepatology
The 43rd European Society For Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)
Past Conference Report
Conference Series LLC Ltd., hosted the 6th International Conference on Hepatology at Hotel Hyatt Regency Osaka, Japan during September 21-22, 2018.The conference was designed around the theme of “Exploring novel trends in Hepatology” and was a great success where eminent keynote speakers from various reputed companies made their resplendent presence and addressed the gathering. Moreover, the networking sessions laid the foundation for some time worthy collaborations between many start-up and big industries. The post conference networking lunch session witnessed a number of B2B meetings that are turning up to be mutually beneficial to both the organizations who had gone in for the business meetings.
Hepatology 2018 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the field of Gastroenterology and Hepatology. This congress not only brought forward the latest developments in the field but also provided solutions to the numerous challenges encountered in developing Hepatology field.
Conference Series LLC Ltd., would like to convey a warm gratitude to all the Honourable guests, Keynote Speakers, Delegates, Media Partners for their participation in Hepatology 2018.
Surgery of the Liver and Intra-operative Interventions. What is possible today?
- Hani Oweira, Hirslanden Group, Zurich
Zhuo Wang, Southern University of Science and Technology, China
We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support and assistance towards the success of Hepatology 2018. With the unique feedbacks from the conference, Conference Series LLC Ltd 7th International Conference on Hepatology during July 15-16, 2019 at Sydney, Australia and also invite you to participate at our other Hepatology conferences.
Let us meet again @ Hepatology 2019
Past Reports Gallery